Submitted by Anonymous (not verified) on 9 December 2025 - 10:15
Human medicines European public assessment report (EPAR): Eviplera, emtricitabine,rilpivirine,tenofovir disoproxil, Date of authorisation: 27/11/2011, Revision: 27, Status: Authorised
Source: